Figure 1

Averages and ranges for the daily consumption of the five nicotine productsa_
| Product | Daily consumption (units/d) | References | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Unit of use | Nb | Mean | SD | Median | Min | Max | 25th Perc. | 75th Perc. | ||
| CC | 1 Cig. | 19 | 15.95 | 1.95 | 16.0 | 12.4 | 18.8 | 14.3 | 16.6 | (B |
| HNB | 1 Stick | 4 | 16.83 | 1.26 | 16.9 | 15.5 | 18 | 15.9 | 17.85 | (G |
| EC | 10 Puffs | 11 | 12.59 | 7.38 | 11.6 | 2.2 | 25 | 7.15 | 21.25 | (E |
| OT (Snus) | 1 g | 8 | 2.62 | 0.98 | 2.53 | 1.20 | 4.24 | 1.98 | 3.05 | (J |
| NRT (NG) | 1 Piece | 9 | 6.35 | 2.30 | 5.15 | 3.2 | 9.45 | 5.00 | 8.50 | (E |
Release of 38 chemicals by the products of interest as well as medians of the estimated daily intakes and corresponding biomarker levels in the 6 user/non-user groups_ The bold numbers in parentheses indicate the relative exposure levels (1 to 4)_ Italic blue numbers in parentheses indicate assumption-based changes (made as described in the text)_ Crossed out values were found to be implausible, a reasonable exposure level assigned instead_ Also these numbers are presented in italic blue_
| Chemical (CAS No) | CC | HNB | EC | OT | NG | NU a | |
|---|---|---|---|---|---|---|---|
| Nicotine-/tobacco-derived chemicals | |||||||
| N (54-11-5) | Content / unit | 0.59–1.67 mg/cig | 0.42–1.19 mg/stick | 0.24–1.38 mg/10 puffs | 10.7–21.0 mg/g | 2.0–4.0 mg/piece | – |
| Intake (mg/d) | 11.7 (4) | 9.01 (4) | 6.99 (3) | 10.58 (4) | 10.35 (4) | 0.05 (1) | |
| Nequ (mg/d) | 14.4 (4) | 7.19 (3) | 9.1 (3) | 11.09 (4) | 7.58 (3) | 0.37 (1) | |
| Cot P (ng/mL) | 215.7 (4) | 161.0 (4) | 187.1 (4) | 143.1 (3) | 137.5 (3) | 0.58 (1) | |
| NN (494-97-3) | Content per unit | 19.98–21.49 μg/cig | 0.02–0.05 μg/stick | 0.55–3.13 μg/10 puffs | 140–173 μg/g | ndab | – |
| Intake (μg/d) | 215.2 (4) | 0.4 (1) | 15.93 (1) | 106.18 (3) | nda (1) | nda (1) | |
| Uptake | No specific biomarker for nornicotine available | ||||||
| AT (581-49-7) | Content per unit | 7.00–13.45 μg/cig | 1.16–1.27 μg/stick | 0.81–34.47 μg/10 puffs | 65.0–84.0 μg/g | nda | – |
| Intake (μg/d) | 105.57 (3) | 13.71 (1) | 152.75 (4) | 50.23 (2) | nda (1) | nda (1) | |
| AT U (μg/d) | 16.28 (3) | nda (1) | 1.01 (1) | 40 (4) | 0.38 (1) | 0.77 (1) | |
| AB (13078-04-1) | Content per unit | 1.12–3.31 μg/cig | 0.21–0.62 μg/stick | 0.0–0.55 μg/10 puffs | 8.50–17.0 μg/g | nda | – |
| Intake (μg/d) | 22.65 (4) | 4.59 (2) | 2.33 (2) | 8.52 (2) | nda (1) | nda (1) | |
| AB U (μg/d) | 15.5 (4) | nda (1) | 1.34 (1) | 20 (4) | 1.12 (1) | 0.76 (1) | |
| NNK (64091-91-4) | Content per unit | 86.9–254 ng/cig | 6.7–7.3 ng/stick | 0.6–1.5 ng/10 puffs | 200–870 ng/g | 0.5–1.5 ng/piece | – |
| Intake (ng/d) | 1740.7 (4) | 79.2 (1) | 9.5 (1) | 352.3 (2) | 3.4 (1) | 10.6 (1) | |
| NNAL U (ng/d) | 347.9 (3) | 104.5c (2) | 26.6 (1) | 539.8 (4) | 176.7c (2) | 2.2 (1) | |
| NNN (16543-55-8) | Content per unit | 96.4–270 ng/cig | 10.5–24.0 ng/stick | 0.4–1.0 ng/10 puffs | 900–2650 ng/g | 1.5–3.0 ng/piece | – |
| Intake (ng/d) | 1876.9 (4) | 194.5 (2) | 6.4 (1) | 1183.2 (3) | 7.7 (1) | nda (1) | |
| NNN U (ng/d) | 17.9 (4) | 3.6 (2) | 2.7 (2) | 8.7 (3) | 2.9 (2) | 2.2 (2) | |
| NAT (71267-22-6) | Content per unit | 141–268 ng/cig | 14.0–20.5 ng/stick | 0.4–1.2 ng/10 puffs | 710–2350 ng/g | 0.5–1.5ng/piece | - |
| Intake (ng/d) | 2111 (4) | 193.2 (1) | 7.1 (1) | 1006 (3) | 3.4 (1) | nda (1) | |
| NAT U (ng/d) | 275.3 (4) | nda (1) | 4.4 (1) | 163.3 (3) | 3.7 (1) | 2.9 (1) | |
| NAB (37620-20-5) | Content per unit | 18–24 ng/cig | 1.9–4.7 ng/stick | 0.1–0.2 ng/10 puffs | 50–180 ng/g | 0.5–0.8 ng/piece | - |
| Intake (ng/d) | 216.8 (4) | 37.2 (2) | 1 (1) | 77.1 (2) | 1.7 (1) | nda (1) | |
| NAB U (ng/d) | 58.8 (4) | nda (1) | 3.8 (1) | 19.9 (2) | 6.1 (2) | 1.3 (1) | |
| PG-/G-derived chemicals | |||||||
| PG (57-55-6) | Content per unit | 0.03–0.60 mg/cig | 0.39–0.63 mg/stick | 49.2–69.9 mg/10 puffs | 5.5–16.5 mg/g | nda | - |
| Intake (mg/d) | 3.2 (1) | 5.8 (1) | 555.3 (4) | 7.3 (1) | nda (1) | 0.005 (1) | |
| PG U (mg/d) | 6.85 (3) | nda (1) | 14.93 (4) | nda (1) | nda (1) | nda (1) | |
| G (56-81-5) | Content per unit | 0.93–2.27 mg/cig | 1.83–3.44 mg/stick | 15.30–67.52 mg/10 puffs | 0.58–8.56 mg/g | nda | - |
| Intake (mg/d) | 16.42 (1) | 29.55 (1) | 360.75 (4) | 3 (1) | nda (1) | 0.003 (1) | |
| Uptake | No suitable biomarker for PG available | ||||||
| Gly (556-52-5) | Content per unit | 3.0–6.0 μg/cig | 22–66 μg/stick | 37.6–59.9 μg/10 puffs | - | - | - |
| Intake (μg/d) | 46.26 (1) | 492.61 (4) | 454.91 (4) | nda (1) | nda (1) | 0.005 (1) | |
| Uptake | No sufficient biomarker data for Gly available | ||||||
| EO (75-21-8) | Content per unit | 14.5–21.8 μg/cig | 0.02–0.20 μg/stick | nda | nda | nda | - |
| Intake (μg/d) | 186.6 (4) | 1.23 (1) | nda (1) | nda (1) | nda (1) | nda (1) | |
| HEMA (μg/d) | 5.23 (4) | 2.53 (3) | 1.8 (2) | 1.194 (2) | |||
| PO (75-56-9) | Content per unit | 1.22–2.14 μg/cig | 0.008–0.148 μg/stick | 0.622–0.992 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 17.27 (4) | 0.88 (1) | 7.53 (3) | nda (1) | nda (1) | nda (1) | |
| 2-HPMA (μg/d) | 72.69 (4) | nda (1) | |||||
| FA (50-00-0) | Content per unit | 40.5–74.0 μg/cig | 4.35–16.5 μg/stick | 1.60–2.02 μg/10 puffs | 0.32–4.5 μg/g | nda | - |
| Intake (μg/d) | 588.93 (4) | 89.35 (2) | 16.86 (1) | 1.02 (1) | nda (1) | 0.08 (1) | |
| Uptake | No biomarker data for FA available | ||||||
| AA (75-07-0) | Content per unit | 1044–1766 μg/cig | 168–212 μg/stick | 0.77–2.30 μg/10 puffs | 1.40–27.4 μg/g | nda | - |
| Intake (μg/d) | 14470 (4) | 2141 (2) | 16.5 (1) | 9.6 (1) | nda (1) | 0.2 (1) | |
| Uptake | No biomarker data for AA available | ||||||
| ACR (107-02-8) | Content per unit | 75–155 μg/cig | 5.3–10.3 μg/stick | 0.5–2.1 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 1176.4 (4) | 87.6 (1) | 11 (1) | nda (1) | nda (1) | 0.007 (1) | |
| 3-HPMA (μg/d) | 1604.3 (4) | 603.9 (2) | 555.4 (2) | 466.5 (2) | 512.5 (2) | 340.5 (2) | |
| CRO (4170-30-3) | Content per unit | 33.7–48.7 μg/cig | 1.1–2.9 μg/stick | 0.5–1.5 μg/10 puffs | 0.2–2.4 μg/g | nda | - |
| Intake (μg/d) | 424.3 (4) | 22.4 (1) | 8.4 (1) | 0.9 (1) | nda (1) | 0.07 (1) | |
| HMPMA (μg/d) | 708.5 (4) | 76.7 (2) | 251.1 (2) | 130.6 (2) | 128.9 (2) | 227.5 (2) | |
| PA (123-38-6) | Content per unit | 111–125 μg/cig | 8.8–13.3 μg/stick | 0.2–0.5 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 1217.8 (4) | 124.3 (2) | 3.0 (1) | nda (1) | nda (1) | 1.9 (1) | |
| Uptake | No biomarker data for PA available | ||||||
| AC (513-86-0) | Content per unit | 2.8–6.2 μg/cig | 2.9–8.7 μg/stick | 0.008–0.023 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 46.42 (4) | 65.19 (4) | 0.13 (1) | nda (1) | nda (1) | 0.0002 (1) | |
| Uptake | No biomarker data for AC available | ||||||
| GO (107-22-2) | Content per unit | 8.8–12.3 μg/cig | 0.03–0.1 μg/stick | 0.24–0.72 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 108.86 (4) | 0.71 (1) | 4.24 (1) | nda (1) | nda (1) | 0.02 (1) | |
| Uptake | No biomarker data for GO available | ||||||
| MGO (78-98-8) | Content per unit | 24.2–31.2 μg/cig | 13.2–39.6 μg/stick | 0.8–1.2 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 285.4 (4) | 297.3 (4) | 9.2 (1) | nda (1) | nda (1) | nda (1) | |
| Uptake | No biomarker data for MGO available | ||||||
| Combustion-derived chemicals | |||||||
| CO (630-08-0) | Content per unit | 22.7–32.0 mg/cig | 0.30–0.53 mg/stick | 0.25–0.75 mg/10 puffs | nda | nda | - |
| Intake (mg/d) | 281.7 (4) | 4.66 (1) | 4.42 (1) | nda (1) | nda (1) | nda (1) | |
| COHb (%) | 5.62 (4) | 1.62 (2) | 1.52 (2) | 1.05 (2) | 1.35 (2) | 1.35 (2) | |
| BD (106-99-0) | Content per unit | 67–100 μg/cig | 0.21–0.40 μg/stick | 0.25–0.75 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 863.24 (4) | 3.43 (1) | 4.48 (1) | nda (1) | nda (1) | nda (1) | |
| MHBMA (μg/d) | 3.54 (4) | 0.108 (1) | 0.381 (2) | 0.707 (2) | 0.438 (2) | ||
| Iso (78-79-5) | Content per unit | 794.9–869.0 μg/cig | 1.96–2.69 μg/stick | 1.25–3.75 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 8607 (4) | 26.91 (1) | 22.1 (1) | nda (1) | nda (1) | 0.29 (1) | |
| IPMA3 (μg/d) | 43.94 (4) | nda (1) | 4.684 (2) | nda (1) | nda (1) | 3.555 (1) | |
| Fu (110-00-9) | Content per unit | 49.3–56.3 μg/cig | 0.58–1.74 μg/stick | - | nda | nda | - |
| Intake (μg/d) | 565.12 (4) | 12.94 (1) | nda (1) | nda (1) | nda (1) | 0.002 (1) | |
| Fu B (ng/mL) | 0.06 (4) | nda (1) | nda (1) | nda (1) | nda (1) | 0.013 (2) | |
| Be (71-43-2) | Content per unit | 62.6–85.2 μg/cig | 0.54–0.63 μg/stick | 0.25–0.75 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 762.57 (4) | 6.82 (1) | 4.45 (1) | nda (1) | nda (1) | 0.52 (1) | |
| SPMA (μg/d) | 1.36 (4) | 0.195 (2) | 0.375 (2) | 0.523 (2) | 0.5 (2) | 0.4 (2) | |
| Sty (100-42-5) | Content per unit | 13.7–24.4 μg/cig | 0.47–1.05 μg/stick | nda | nda | nda | - |
| Intake (μg/d) | 195.6 (4) | 8.52 (1) | nda (1) | nda (1) | nda (1) | 6.6 (1) | |
| PHEMA (μg/d) | 1.22 (4) | nda (2) | nda (2) | ||||
| AN (107-13-1) | Content per unit | 15.8–24.5 μg/cig | 0.16–0.26 μg/stick | 0.131–0.38 μg/10 puffs | nda | nda | - |
| Intake (μg/d) | 208.5 (4) | 2.4 (1) | 2.2 (1) | nda (1) | nda (1) | 0.17 (1) | |
| CEMA (μg/d) | 162.6 (4) | 17.2 (2) | 36.6 (2) | 37.7 (2) | 29 (2) | 1.8 (1) | |
| AM (79-06-1) | Content per unit | 4.4–4.8 μg/cig | 1.04–1.73 μg/stick | nda | nda | nda | - |
| Intake (μg/d) | 47.4 (4) | 15.6 (2) | nda (1) | nda (1) | nda (1) | 0.002 (1) | |
| AAMA (μg/d) | 164.9 (4) | 88.8 (3) | 53.3 (2) | 42 (2) | 66.1 (3) | ||
| HCN (74-90-8) | Content per unit | 327–356 μg/cig | 1.7–3.5 μg/stick | nda | nda | nda | - |
| Intake (μg/d) | 3529 (4) | 29.5 (1) | nda (1) | nda (1) | nda (1) | nda (1) | |
| SCN P (μg/d) | 123.8 (4) | nda (3) | nda (3) | 80.6 (3) | nda (3) | 75 (3) | |
| o-Tol (95-53-4) | Content per unit | 62–84 ng/cig | 0.5–1.0 ng/stick | nda | nda | nda | - |
| Intake (ng/d) | 750.8 (4) | 8.0 (1) | nda (1) | nda (1) | nda (1) | 280 (2) | |
| o-Tol U (ng/d) | 201 (4) | 56.7 (2) | 100.1(3) | 114 (3) | 96.9 (3) | 63.5 (2) | |
| 2-NA (91-59-8) | Content per unit | 10–14 ng/cig | 0.02–0.05 ng/stick | 0.25–0.75 ng/10 puffs | nda | nda | - |
| Intake (ng/d) | 121.7 (4) | 0.4 (1) | 4.4 (1) | nda (1) | nda (1) | ||
| 2-NA U (ng/d) | 27.6 (4) | 1.8 (1) | 2.5 (1) | 3.3 (2) | 2.6 (1) | 3.5 (2) | |
| 4-ABP (92-67-1) | Content per unit | 2.0–2.8 ng/cig | 0.003–0.02 ng/stick | 0.01–0.04 ng/10 puffs | nda | nda | - |
| Intake (ng/d) | 25.1 (4) | 0.1 (1) | 0.2 (1) | nda (1) | nda (1) | ||
| 4-ABP U (ng/d) | 20.9 (4) | 2.3 (2) | 7 (2) | 3.8 (2) | 6.9 (2) | 2.4 (2) | |
| Nap (91-20-3) | Content per unit | 0.9–1.2 μg/cig | 0.002–0.004 μg/stick | nda | nda | nda | - |
| Intake (μg/d) | 10.86 (4) | 0.03 (1) | nda (1) | nda (1) | nda (1) | 4.33 (2) | |
| 1-OH-Nap (μg/d) | 13.28 (4) | nda (1) | 1.94 (2) | 2.59 (2) | nda (1) | 1.98 (2) | |
| Combustion-derived chemicals | |||||||
| Flu (86-73-7) | Content per unit | 237–337 ng/cig | 1.5–5.4 ng/stick | nda | nda | nda | - |
| Intake (μg/d) | 2.91 (4) | 0.04 (1) | nda (1) | nda (1) | nda (1) | 0.006 (1) | |
| 2-OH-Flu (μg/d) | 1.94 (4) | nda (1) | 1.05 (3) | 0.61 (2) | 1.05 (3) | 0.58 (2) | |
| Phe (85-01-8) | Content per unit | 159–292 ng/cig | 1.0–2.0 ng/stick | nda | nda | nda | - |
| Intake (ng/d) | 2323 (4) | 16.7 (1) | nda (1) | nda (1) | nda (1) | 76.5 (1) | |
| 1-OH-Phe (ng/d) | 221.9 (4) | nda (1) | 133.8 (3) | 152.2 (3) | nda (1) | 122.9 (3) | |
| Pyr (129-00-0) | Content per unit | 79–89 ng/cig | 2–7 ng/stick | nda | nda | nda | - |
| Intake (ng/d) | 871.7 (4) | 51.1 (1) | nda (1) | nda (1) | nda (1) | 114.8 (2) | |
| 1-OH-Pyr (ng/d) | 305 (4) | 70 (1) | 139 (2) | ||||
| BaP (50-32-8) | Content per unit | 13–16 ng/cig | 0.2–0.8 ng/stick | 0.25–0.75 ng/10 puffs | 1.4–60.4 ng/g | nda | - |
| Intake (ng/d) | 149.1 (4) | 5.5 (1) | 4.4 (1) | 20.4 (2) | nda (1) | 76.5 (3) | |
| 3-OH-BaP (ng/d) | 203.1 (4) | 36.9 (2) | 78.9 (2) | 61.9 (2) | |||
Complete biomarker exposure level-derived patterns for the 6 groups of single product users (or non-users) as well as 3 dual user groups_
| Group | Pattern (based on 30 biomarker levels in the order as presented in Table 2), pattern for dual users calculated as described in the text |
|---|---|
| CC | 443434443344444444444444444444 |
| HNB | 341122121212221112223321211122 |
| EC | 341112114222222212222322222222 |
| OT | 434443321222222112222322222222 |
| NG | 331122121222222112222321212122 |
| NU | 111112111222222122213322222222 |
| CC/HNB | 442333332333333333334433333333 |
| CC/EC | 442323334333333333333433333333 |
| CC/OT | 444444432333333333333433333333 |
Uniqueness of single biomarker levels for particular product users or non-users_
| Users | ||||
|---|---|---|---|---|
| Biomarkera | Level | Biomarkera | Level | |
| CC | NAB (u) | > 41 ng/d | NNN (u) | > 12.5 ng/d |
| 3-HPMA (u) | > 1123 μg/d | NAT (u) | > 193 ng/d | |
| HMPMA (u) | > 496 μg/d | MHBMA (u) | > 2.5 μg/d | |
| COHb (b) | > 3.9% | SCN (p, u, sa) | > 87 μM | |
| IPMA3 (u) | > 30.8 μg/d | o-Tol (u) | > 141 ng/d | |
| Fu (b) | > 0.04 ng/d | 2-OH-Flu (u) | > 1.36 μg/d | |
| SPMA (u) | > 0.95 μg/d | 1-OH-Phe | > 155 ng/d | |
| CEMA (u) | > 113.8 μg/d | 3-OH-BaP | > 142 pg/d | |
| 2-NA (u) | > 19.3 ng/d | |||
| 4-ABP (u) | > 14.6 ng/d | |||
| 1-OH-Nap (u) | > 9.3 μg/d | |||
| HNB | none | none | ||
| EC | PG (u) | > 4.4 mg/d | ||
| OT | none | NNAL (u) | > 378 ng/d | |
| NG | none | none | ||
| NU | Nequ (u) | < 0.037 mg/d | CEMA (u) | < 16.1 μg/d |
| Cotinine (p) | < 21.4 ng/mL | |||